Esperion Therapeutis.Inc. buy El_Zocko
Start price
29.09.15
/
50%
€20.64
Target price
20.10.16
€35.00
Performance (%)
-47.70%
End price
20.10.16
€10.79
Summary
This prediction ended on 20.10.16 with a price of €10.79. The BUY prediction by El_Zocko for Esperion Therapeutis.Inc. performed very badly with a performance of -47.70%. El_Zocko has 50% into this predictionEsperion Therapeutics, Inc. (NASDAQ: ESPR) is a biopharmaceutical company primarily focused on the development and commercialization of innovative lipid management therapies to address the unmet medical needs of patients with high cholesterol. With its flagship products, NEXLETOL® and NEXLIZET®, the company aims to provide alternative treatment options for individuals who cannot tolerate statins or require additional LDL-C lowering despite statin therapy. Esperion is driven by its commitment to improve cardiovascular health globally and maintains a steadfast dedication to researching and developing advanced cholesterol-lowering therapies.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Esperion Therapeutis.Inc. | 0.399% | 0.399% | 172.539% | 106.334% |
| iShares Core DAX® | -0.097% | 0.537% | 3.314% | 53.015% |
| iShares Nasdaq 100 | 0.585% | -2.390% | 30.855% | 87.448% |
| iShares Nikkei 225® | -0.055% | -2.746% | 60.149% | 76.075% |
| iShares S&P 500 | 0.939% | 1.287% | 23.985% | 70.005% |
Comments by El_Zocko for this prediction
In the thread Esperion Therapeutis.Inc. diskutieren
Schlimmer geht nimmer?
Hoffen wir es!!
(Laufzeit überschritten)